1. Home
  2. JSPR vs CRT Comparison

JSPR vs CRT Comparison

Compare JSPR & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JSPR
  • CRT
  • Stock Information
  • Founded
  • JSPR 2018
  • CRT 1991
  • Country
  • JSPR United States
  • CRT United States
  • Employees
  • JSPR N/A
  • CRT N/A
  • Industry
  • JSPR Biotechnology: Biological Products (No Diagnostic Substances)
  • CRT Oil & Gas Production
  • Sector
  • JSPR Health Care
  • CRT Energy
  • Exchange
  • JSPR Nasdaq
  • CRT Nasdaq
  • Market Cap
  • JSPR 47.6M
  • CRT 45.2M
  • IPO Year
  • JSPR N/A
  • CRT 1992
  • Fundamental
  • Price
  • JSPR $2.45
  • CRT $7.15
  • Analyst Decision
  • JSPR Buy
  • CRT
  • Analyst Count
  • JSPR 11
  • CRT 0
  • Target Price
  • JSPR $28.00
  • CRT N/A
  • AVG Volume (30 Days)
  • JSPR 439.0K
  • CRT 27.2K
  • Earning Date
  • JSPR 11-06-2025
  • CRT 01-01-0001
  • Dividend Yield
  • JSPR N/A
  • CRT 10.37%
  • EPS Growth
  • JSPR N/A
  • CRT N/A
  • EPS
  • JSPR N/A
  • CRT 0.92
  • Revenue
  • JSPR N/A
  • CRT $6,559,820.00
  • Revenue This Year
  • JSPR N/A
  • CRT N/A
  • Revenue Next Year
  • JSPR N/A
  • CRT N/A
  • P/E Ratio
  • JSPR N/A
  • CRT $7.93
  • Revenue Growth
  • JSPR N/A
  • CRT N/A
  • 52 Week Low
  • JSPR $2.22
  • CRT $7.12
  • 52 Week High
  • JSPR $26.05
  • CRT $13.31
  • Technical
  • Relative Strength Index (RSI)
  • JSPR 46.88
  • CRT 28.68
  • Support Level
  • JSPR $2.33
  • CRT $7.38
  • Resistance Level
  • JSPR $2.65
  • CRT $7.72
  • Average True Range (ATR)
  • JSPR 0.15
  • CRT 0.18
  • MACD
  • JSPR 0.03
  • CRT 0.01
  • Stochastic Oscillator
  • JSPR 53.32
  • CRT 4.76

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

About CRT Cross Timbers Royalty Trust

Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.

Share on Social Networks: